The 10-second takeaway
For the quarter ended June 30 (Q2), SciQuest met expectations on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP earnings per share dropped.
Margins shrank across the board.
SciQuest logged revenue of $15.2 million. The eight analysts polled by S&P Capital IQ expected sales of $15.1 million on the same basis. GAAP reported sales were 18% higher than the prior-year quarter's $12.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.06. The seven earnings estimates compiled by S&P Capital IQ predicted $0.06 per share. GAAP EPS of $0.02 for Q2 were 33% lower than the prior-year quarter's $0.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 71.0%, 470 basis points worse than the prior-year quarter. Operating margin was 5.4%, 350 basis points worse than the prior-year quarter. Net margin was 2.6%, 190 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $17.7 million. On the bottom line, the average EPS estimate is $0.06.
Next year's average estimate for revenue is $66.7 million. The average EPS estimate is $0.24.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 17 members rating the stock outperform and four members rating it underperform. Among 11 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), eight give SciQuest a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on SciQuest is buy, with an average price target of $19.61.
- Add SciQuest to My Watchlist.